Heres an interesting statement about this new drug:

Amgen's colon cancer drug Vectibix was approved by the FDA based on the results of a clinical trial, which enrolled 463 patients with metastatic cancer of the colon and the rectum who underwent treatment with chemotherapy drugs. In patients who were treated with Vectibix, the mean time to disease progression or death was 96 days compared to 60 days who received standard chemotherapy treatment. In addition, the size of the tumors was reduced by over 50% in 8% of the patients who were administered Vectibix.

So patients are getting an extra 5 weeks with this "discounted" drug?


http://www.finwin.com/finwin/home/he...9895013&id=997

paula